HiiMS

Chandigarh, India Listed
Integrated Ayurvedic and medical services for disease management in India.

About HiiMS

HiiMS is a publicly listed company based in Chandigarh (India). Integrated Ayurvedic and medical services for disease management in India. The company has 3,550 employees. Its Indian entity Jeena Sikho Lifecare Limited reported revenue of ₹810 Cr. HiiMS offers products and services including Ayurvedic Treatments and Consultations. Its focus areas include Wellness, Alternative Therapies, Ayurveda and Medical Services.

Company details

HiiMS is known for delivering integrated healthcare services that combine Ayurveda with modern practices across India. A network of over 55 hospitals and 70 clinics is utilized to treat conditions like kidney disease, diabetes, and cancer through natural therapies and patient education. Emphasis is placed on holistic approaches, including diet, yoga, and lifestyle modifications, to promote self-reliance in health. These services are accessed by thousands of patients annually, focusing on reversal of chronic diseases without side effects.

Key Metrics
  • Market Cap
    ₹3,729 Cr

    JSLL · NSE

  • Share Price
    ₹296.35

    -1.20% today

  • Revenue
    ₹801 Cr

    FY 2025-26

  • EBITDA
    ₹349 Cr

    Margin 43.6%

  • Net Profit
    ₹222 Cr

    FY 2025-26

  • P/E (TTM)
    18.0x

    P/B 7.5x

  • ROE
    61.3%

    ROCE 63.7%

  • Debt / Equity
    0.34

    Interest cover 4.6x

  • Employee Count
    3,550

Products & Services of HiiMS

HiiMS offers a comprehensive portfolio of products and services, including Ayurvedic Treatments and Consultations.

Ayurvedic Treatments
Healthcare Services

Ayurvedic treatments are provided for various diseases using natural therapies and integrated methods

Consultations
Medical Services

Consultations are offered through OPD, virtual platforms, and home services to support patient health management

Apps and channels of HiiMS

its YouTube channel HIIMS has 1.12M subscribers and 30 videos.

HIIMS
YouTube 1.12M subscribers 30 videos Howto & Style
Open channel

Videos from HiiMS

The most watched videos on HiiMS's YouTube channel, HIIMS (1.12M subscribers). Click a video to play it here.

बीमारियों की जड़ | Low Metabolism & Digestion | Body Detoxification | Acharya Manish JI
14.6K views
ऐसे रखें बीमारियों को दूर | PH Balance Diet Chart Plan | Weight Loss | Acharya Manish JI
11.8K views
Gallbladder Stone & Cancer | बार -बार क्यों लौटा कैंसर? | Cyst/Tumor Treatment in Ayurveda | HiiMS
1.2K views
रोगों का कारण | How to Prevent All Diseases | Comedian Bharti Weight Loss Secret | Acharya Manish JI
1.1K views

More on HIIMS.

Board of directors of Jeena Sikho Lifecare Limited (HiiMS)

Jeena Sikho Lifecare Limited is the primary company behind HiiMS. The board of Jeena Sikho Lifecare Limited currently have 10 directors; the longest-serving is Shreya Grover, appointed in 2021. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Shreya Grover
DIN 09199495
Whole-time director12 Jun 20215 yrs 5 moJeena Sikho Lifecare Limited
Karan Vir Bindra
DIN 09283623
Director25 Aug 20215 yrs 2 moJeena Sikho Lifecare Limited
Manish Grover
DIN 07557886
Managing Director25 Aug 20215 yrs 2 moJeena Sikho Lifecare Limited
Bhavna Grover
DIN 07557913
Whole-time director25 Aug 20215 yrs 2 moJeena Sikho Lifecare Limited
Chandan Kumar Kaushal
DIN 10515819
Director29 Apr 20242 yrs 6 moJeena Sikho Lifecare Limited
Priyanka Bansal
DIN 09051665
Director21 Apr 20251 yr 6 moJeena Sikho Lifecare Limited
Ankush Kaushal
DIN 03308862
Whole-time director15 Jul 20264 moJeena Sikho Lifecare Limited
Ajay Sharma
DIN 07671350
Director15 Jul 20264 moJeena Sikho Lifecare Limited
Sapna Singh
DIN 11812894
Director15 Jul 20264 moJeena Sikho Lifecare Limited
Ish Sharma
DIN 11815526
Whole-time director15 Jul 20264 moJeena Sikho Lifecare Limited

IPO & Listings of HiiMS

HiiMS is a publicly listed company on the NSE with ticker symbol JSLL in India, operating in the Pharmaceuticals sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: JSLL
  • Listed entityJeena Sikho Lifecare Limited
  • Exchange sectorPharmaceuticals

Financials of HiiMS

Exchange-reported figures of Jeena Sikho Lifecare Limited, the listed company behind HiiMS (NSE: JSLL).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹801 Cr
+291.4% YoY
EBITDA
₹349 Cr
+662.1% YoY
Profit After Tax
₹222 Cr
+564.5% YoY
Net Worth
₹467 Cr
+271.3% YoY
Total Assets
₹601 Cr
+374.2% YoY
Total Debt
₹127 Cr
- YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2022-23FY 2021-22
Income statement
Revenue801205147
Revenue growth-+39.7%-
EBITDA34945.8518.09
EBITDA margin+43.6%+22.4%+12.3%
Profit before tax29744.3015.09
Net profit22233.3910.65
Net profit margin+27.7%+16.3%+7.3%
EPS (₹)17.8124.4611.11
Balance sheet
Total assets60112744.00
Net worth46712636.51
Total debt1270.817.43
Cash & bank10932.392.59
Net working capital17248.594.26
Cash flow
Cash from operations25414.5216.35
Cash from investing(202)(33.10)(18.49)
Cash from financing(58.68)48.00(4.51)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue235224216222190174139116
Revenue growth (YoY)+23.9%+28.8%+54.8%+91.6%+66.4%+74.2%--
Other income(1.94)14.333.422.571.441.070.270.39
EBITDA71.9992.0677.9210192.0378.7645.7729.61
EBITDA margin+30.6%+41.0%+36.1%+45.4%+48.5%+45.2%+32.9%+25.6%
Depreciation16.4915.3916.3811.2610.409.659.038.47
Interest4.043.473.733.104.351.663.103.79
Profit before tax49.5287.5361.2388.9378.7268.5233.9117.74
Tax12.9021.6416.1422.3319.9717.248.584.53
Net profit36.6265.8945.0966.6058.7551.2825.3313.21
EPS (₹)2.945.293.625.354.724.122.041.06
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue80146932420414613694.42
Revenue growth+70.8%+44.6%+59.1%+39.2%+7.8%+43.8%-
EBITDA35012593.0146.3218.1616.9610.55
EBITDA margin+43.6%+26.7%+28.7%+22.7%+12.4%+12.5%+11.2%
Profit before tax29812293.9244.5215.1614.217.73
Net profit22288.2567.8733.3410.6810.425.74
Net profit margin+27.7%+18.8%+20.9%+16.4%+7.3%+7.7%+6.1%
EPS (₹)17.8536.5027.8424.4311.151,015.21572.63
Balance sheet
Total assets60137719312744.0736.4626.41
Net worth46725619212636.5523.9513.73
Total debt1271170.540.817.4312.0312.46
Cash & bank10822.9862.0132.392.578.961.44
Net working capital16390.0911448.594.8313.709.46
Cash flow
Cash from operations26284.5036.6917.1717.4817.5311.74
Cash from investing(211)(64.38)(18.05)(57.23)(19.64)(8.47)(5.97)
Cash from financing(58.73)(22.45)(3.44)48.00(4.51)(1.53)(5.05)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue235224216222190174139116
Revenue growth (YoY)+23.9%+28.8%+54.8%+91.6%+66.4%+74.2%--
Other income(2.31)14.023.582.571.441.070.270.39
Total expenses16313213812197.7895.5093.4886.08
EBITDA72.0392.1277.9810192.0778.7945.7729.61
EBITDA margin+30.6%+41.1%+36.2%+45.5%+48.5%+45.2%+32.9%+25.6%
Depreciation16.4315.3316.3211.2110.409.659.038.47
Interest4.043.473.733.104.351.663.103.79
Profit before tax49.2587.3461.5189.0578.7668.5533.9117.74
Tax12.9121.6516.1522.3319.9717.248.584.53

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 19 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue235224216222190174139116
Revenue growth (YoY)+23.9%+28.8%+54.8%+91.6%+66.4%+74.2%--
Other income(1.94)14.333.422.571.441.070.270.39
EBITDA71.9992.0677.9210192.0378.7645.7729.61
EBITDA margin+30.6%+41.0%+36.1%+45.4%+48.5%+45.2%+32.9%+25.6%
Depreciation16.4915.3916.3811.2610.409.659.038.47
Interest4.043.473.733.104.351.663.103.79
Profit before tax49.5287.5361.2388.9378.7268.5233.9117.74
Tax12.9021.6416.1422.3319.9717.248.584.53
Net profit36.6265.8945.0966.6058.7551.2825.3313.21
EPS (₹)2.945.293.625.354.724.122.041.06
ParticularsFY 2025-26FY 2022-23FY 2021-22
Revenue801205147
Revenue growth-+39.7%-
Other income8.502.601.49
Total expenses452159128
Employee cost0.0044.0533.80
EBITDA34945.8518.09
EBITDA margin+43.6%+22.4%+12.3%
Depreciation47.693.203.31
Interest12.830.951.18
Profit before tax29744.3015.09
Tax75.6910.773.89
Net profit22233.3910.65
Net profit margin+27.7%+16.3%+7.3%
EPS (₹)17.8124.4611.11
ParticularsFY 2025-26FY 2022-23FY 2021-22
Equity & liabilities
Share capital24.8613.8110.11
Reserves & surplus44211226.40
Shareholders' funds (net worth)46712636.51
Minority interest(0.13)0.00(0.03)
Secured loans0.430.811.08
Unsecured loans1270.006.35
Total debt1270.817.43
Total liabilities60112744.00
Assets
Gross block38470.7636.84
Net block29359.7428.59
Capital work in progress2.861.135.04
Investments1104.550.00
Inventories20.224.106.36
Sundry debtors69.9322.079.04
Cash & bank balances10932.392.59
Loans & advances46.7814.363.53
Total current assets24672.9221.52
Total current liabilities73.4324.3317.26
Net working capital17248.594.26
Total assets60112744.00
ParticularsFY 2025-26FY 2022-23FY 2021-22
Opening cash22.982.198.84
Net cash from operating activities25414.5216.35
Net cash from investing activities(202)(33.10)(18.49)
Net cash from financing activities(58.68)48.00(4.51)
Net change in cash(6.61)29.42(6.65)
Closing cash10932.392.59
ParticularsFY 2025-26FY 2024-25FY 2022-23FY 2021-22
Growth
Sales growth-+129.1%+39.7%-
EBITDA growth-+206.7%+153.5%-
PBT growth+176.5%+142.8%+193.6%+9997.0%
Net income growth-+132.4%+213.5%-
Revenue CAGR (3Y)+76.2%---
EBITDA CAGR (3Y)+168.6%---
Profitability & leverage
Net income margin+27.7%+17.0%+16.4%+7.6%
Return on capital employed+63.7%+31.4%+53.0%+37.0%
Return on net worth+61.3%+31.2%+41.3%+30.7%
Debt / equity0.340.460.050.20
Long-term debt / equity0.250.330.010.02
Interest cover4.589.552.237.98
Efficiency & per share
Fixed asset turnover2.351.583.813.98
Inventory turnover50.4540.6139.1523.04
Debtors turnover10.355.5213.1616.21
EPS (₹)17.8432.1624.4611.11
Dividend per share (₹)4.505.472.000.00
Book value per share (₹)37.58103.1191.0936.11
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue235224216222190174139116
Revenue growth (YoY)+23.9%+28.8%+54.8%+91.6%+66.4%+74.2%--
Other income(2.31)14.023.582.571.441.070.270.39
Total expenses16313213812197.7895.5093.4886.08
EBITDA72.0392.1277.9810192.0778.7945.7729.61
EBITDA margin+30.6%+41.1%+36.2%+45.5%+48.5%+45.2%+32.9%+25.6%
Depreciation16.4315.3316.3211.2110.409.659.038.47
Interest4.043.473.733.104.351.663.103.79
Profit before tax49.2587.3461.5189.0578.7668.5533.9117.74
Tax12.9121.6516.1522.3319.9717.248.584.53
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue80146932420414613694.42
Revenue growth+70.8%+44.6%+59.1%+39.2%+7.8%+43.8%-
Other income8.666.416.442.281.491.070.76
Total expenses45234423115812811983.87
Employee cost0.0010065.9143.4433.7530.3821.65
EBITDA35012593.0146.3218.1616.9610.55
EBITDA margin+43.6%+26.7%+28.7%+22.7%+12.4%+12.5%+11.2%
Depreciation47.588.715.103.133.312.461.94
Interest12.830.970.430.951.181.361.64
Profit before tax29812293.9244.5215.1614.217.73
Tax75.7031.3424.7110.783.893.891.99
Net profit22288.2567.8733.3410.6810.425.74
Net profit margin+27.7%+18.8%+20.9%+16.4%+7.3%+7.7%+6.1%
EPS (₹)17.8536.5027.8424.4311.151,015.21572.63
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital24.8624.8624.8613.8110.110.100.10
Reserves & surplus44323116711226.4423.8513.63
Shareholders' funds (net worth)46725619212636.5523.9513.73
Secured loans0.430.740.540.811.080.230.66
Unsecured loans1271160.000.006.3511.8011.80
Total debt1271170.540.817.4312.0312.46
Total liabilities60137719312744.0736.4626.41
Assets
Gross block38329882.3870.7636.5928.3319.98
Net block29225366.8559.7428.3422.6816.66
Capital work in progress2.7113.483.941.135.040.000.00
Investments1103.564.144.550.010.000.00
Inventories20.1711.557.194.105.769.2810.56
Sundry debtors69.9384.9641.1922.078.973.244.38
Cash & bank balances10822.9862.0132.392.578.961.44
Loans & advances37.5012.5830.4614.364.744.614.54
Total current assets23513214172.9222.0426.0920.92
Total current liabilities71.8941.9827.1924.3317.2112.3911.46
Net working capital16390.0911448.594.8313.709.46
Total assets60137719312744.0736.4626.41
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash22.9825.3110.122.178.841.440.71
Net cash from operating activities26284.5036.6917.1717.4817.5311.74
Net cash from investing activities(211)(64.38)(18.05)(57.23)(19.64)(8.47)(5.97)
Net cash from financing activities(58.73)(22.45)(3.44)48.00(4.51)(1.53)(5.05)
Net change in cash(7.82)(2.34)15.207.94(6.67)7.530.73
Closing cash10822.9862.0132.392.578.961.44
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+70.8%+44.6%+59.1%+39.2%+7.8%+43.8%-
EBITDA growth+179.0%+34.8%+100.8%+155.1%+7.1%+60.8%-
PBT growth+176.9%+14.5%+111.0%+193.7%+6.7%+83.8%-7.1%
Net income growth+151.8%+30.0%+103.6%+212.2%+2.5%+81.5%-
Revenue CAGR (3Y)+57.8%+47.4%+33.7%+29.3%+11.4%--
EBITDA CAGR (3Y)+96.4%+97.8%+76.4%+63.8%+19.6%--
Profitability & leverage
Net income margin+27.7%+17.0%+21.3%+16.6%+7.7%+7.6%+6.1%
Return on capital employed+63.7%+41.5%+59.0%+53.3%+40.6%+49.4%+37.4%
Return on net worth+61.4%+35.6%+43.5%+41.6%+37.3%+54.6%+52.7%
Debt / equity0.340.260.000.050.320.651.29
Long-term debt / equity0.250.190.000.010.020.020.05
Interest cover4.589.550.492.207.959.3819.05
Efficiency & per share
Fixed asset turnover2.352.474.243.804.515.625.55
Inventory turnover50.5350.0657.4741.3619.4713.698.13
Debtors turnover10.357.4410.2613.1423.9935.6522.01
EPS (₹)17.8732.1627.8424.4311.151,015.21572.63
Dividend per share (₹)4.505.474.802.000.000.000.00
Book value per share (₹)37.60103.1177.3391.0936.152,362.311,372.83

Web traffic of HiiMS

Websites that share an audience with HiiMS (hiims.in).

Similar websites

Websites whose visitors overlap most with HiiMS. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
aryavaidyasala.com
84%
339.5K#115,508View details
drvaidyas.com
83%
292.3K#213,781View details
kimshospitals.com
82%
357.2K#91,559View details
bombayhospitalindore.com
79%
12.2K#1,243,045View details
regencyhealthcare.in
78%
33.5K#931,629View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 15 similar websites and full traffic analytics for HiiMS

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 15 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Alternative Medicine Products

3 companies that operate in the same segment as HiiMS (Alternative Medicine Products) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Homeopathic medicine manufacturing and online retail in India.
1898Noida, Uttar Pradesh, IndiaUSD 26.35 M1,192
Operates an online store specializing in ayurvedic and homeopathic medicines.
2016Delhi, Delhi, IndiaUSD 1.25 M16
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness.
1992Faridabad, Haryana, IndiaUSD 10.08 M570
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Hiims

Jeena Sikho Lifecare: Starts Working at New 17,700 Sq. Ft. Client Support Center in Noida.
Exchange Update • 1 day ago
Jeena Sikho Lifecare: Launches Eight New Ayurvedic and Nutraceutical Products, Featuring Pain Relief and Plant Protein Options.
Exchange Update • 1 month ago
Jeena Sikho Lifecare: To Hold Analyst And Investor Meeting On September 29 At 11 AM
Exchange Update • 1 month ago
Premium access

Complete news archive for HiiMS

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about HiiMS

HiiMS is headquartered in Chandigarh, India.

HiiMS has 3,550 employees.

The primary company behind HiiMS, Jeena Sikho Lifecare Limited, reported revenue of ₹810 Cr for FY 2026, up 291% year on year.

HiiMS is known for delivering integrated healthcare services that combine Ayurveda with modern practices across India. A network of over 55 hospitals and 70 clinics is utilized to treat conditions like kidney disease, diabetes, and cancer through natural therapies and patient education. Emphasis is placed on holistic approaches, including diet, yoga, and lifestyle modifications, to promote self-reliance in health. These services are accessed by thousands of patients annually, focusing on reversal of chronic diseases without side effects.

HiiMS offers Ayurvedic Treatments and Consultations.

Yes, HiiMS is publicly traded on NSE under the ticker symbol JSLL.

HiiMS operates through Jeena Sikho Lifecare Limited.

The legal entities of HiiMS currently have 12 directors, including Karan Vir Bindra, Manish Grover, Shreya Grover and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available